SNMMI Procedure Standard for Scintigraphy for Differentiated Thyroid Cancer
- 3 September 2020
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine Technology
- Vol. 48 (3) , 202-209
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- One Month Is Sufficient for Urinary Iodine to Return to Its Baseline Value After the Use of Water-Soluble Iodinated Contrast Agents in Post-Thyroidectomy Patients Requiring Radioiodine TherapyThyroid®, 2012
- Thyroid Stunning: Fact or Fiction?Seminars in Nuclear Medicine, 2011
- Dietary Iodine Restriction in Preparation for Radioactive Iodine Treatment or Scanning in Well-Differentiated Thyroid Cancer: A Systematic ReviewThyroid®, 2010
- Gynaecological masses: imaging and pathologyCancer Imaging, 2010
- Is the Serum Thyroglobulin Response to Recombinant Human Thyrotropin Sufficient, by Itself, to Monitor for Residual Thyroid Carcinoma?The Journal of Clinical Endocrinology & Metabolism, 2002
- Implication of 2- 18 Fluor-2-Deoxyglucose Positron Emission Tomography in the Follow-Up of Hürthle Cell Thyroid CancerThyroid®, 2002
- Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2000
- Detection of Thyroid Remnant/Metastasis Without Stunning: An Ongoing DilemmaThyroid®, 1997
- Selection of the Optimal Scanning Agent for Thyroid CancerThyroid®, 1997
- Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinomaThe Journal of Clinical Endocrinology & Metabolism, 1994